FY2025 SEC EDGAR DEF 14A #9 of 168 in industry

Teva Pharmaceutical Industries Ltd CEO pay ratio

The CEO earned $19.2M in FY2025 against median worker pay of $74,725 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
L3
Filing date
2026-03-31
Industry
Chemicals & Pharmaceuticals
Industry rank
#9/168

Data updated August 2026

Subscribe to Teva Pharmaceutical Industries Ltd CEO pay filing updates (RSS)

CEO-to-worker pay ratio
257:1
High (Scale: 0–1000:1)
CEO pay
$19.2M
Median worker
$74,725

Answer first

Teva Pharmaceutical Industries Ltd's FY2025 CEO total of $19.2M ranks #184 of 1,423 complete filings; its 257:1 pay ratio ranks #242. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $74,725. Industry placement uses the FY2025 SIC-28 peer cohort (# 9 of 168, 95th percentile - top 5% of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#184
$19.2M of 1,423 FY2025
Ratio rank
#242
257:1 of 1,423
Industry pct
95th
top 5% of industry peers by pay ratio

How Teva Pharmaceutical Industries Ltd ranks nationally

Teva Pharmaceutical Industries Ltd CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$19,168,709 Top 13% higher than 87% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). Below this entry. $12,500,000–$15,000,000: 91 companies (6%). Below this entry. $15,000,000–$17,500,000: 88 companies (6%). Below this entry. $17,500,000–$20,000,000: 54 companies (4%). This entry sits in this band. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Teva Pharmaceutical Industries Ltd vs. Chemicals & Pharmaceuticals peers

CEO total pay ($19.2M) against pay ratio (257:1) for Teva Pharmaceutical Industries Ltd (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both6588563.312087708.917586854.523086000.128585145.630.3:194.9:1159.5:1224.1:1288.8:1CEO total payPay ratio (CEO : median worker)Teva Pharmaceutical Industries Ltd, CEO total pay: 19168709 · Pay ratio (CEO : median worker): 257:1Teva Pharmaceutical Industries LtdHarrow, Inc., CEO total pay: 23606274 · Pay ratio (CEO : median worker): 263:1Harrow, Inc.Trulieve Cannabis Corp., CEO total pay: 7588408 · Pay ratio (CEO : median worker): 243:1Trulieve Cannabis Corp.International Flavors & Fragrances Inc, CEO total pay: 15015892 · Pay ratio (CEO : median worker): 239:1International Flavors & Fragrances IncPfizer Inc, CEO total pay: 27585301 · Pay ratio (CEO : median worker): 277:1Pfizer IncZoetis Inc., CEO total pay: 19019712 · Pay ratio (CEO : median worker): 236:1Zoetis Inc.
Teva Pharmaceutical Industries Ltd vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Teva Pharmaceutical Industries Ltd's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Teva Pharmaceutical Industries Ltd

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
257:1
FY2025
vs prior FY
+23:1
from FY2024 234:1
CEO $ YoY
+24%
$19.2M latest
Filings shown
5
FY2021–2025
Teva Pharmaceutical Industries Ltd CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $14.7M - $75,944 193:1 -
2022 $15.5M +5.8% $74,779 208:1 +15:1
2023 $25.7M +66% $64,562 398:1 +190:1
2024 $15.5M -40% $66,199 234:1 -164:1
2025 $19.2M +24% $74,725 257:1 +23:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 818686, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
257:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$19.2M
Companies in Industry
168
vs. Industry Median
Above
#9 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Teva Pharmaceutical Industries Ltd: STEEP · PEAK pay ratio

Teva Pharmaceutical Industries Ltd's FY2025 ratio 257:1 ranks #9 of 168 Chemicals & Pharmaceuticals filers (95th percentile). the CEO earned 257× the median employee ($74,725) in FY2025.

Median employee $74,725 (HIGH-MED); STEEP · PEAK stamps put about 257 median-wage years per CEO year.

CEO Total Pay

$19.2M

FY2025 Summary Compensation, well above median

Pay Ratio

257:1

Elevated vs. peers

Teva Pharmaceutical Industries Ltd in the higher Chemicals & Pharmaceuticals third

Teva Pharmaceutical Industries Ltd's FY2025 ratio 257:1 ranks #9 of 168 Chemicals & Pharmaceuticals filers (95th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Teva Pharmaceutical Industries Ltd's $19.2M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #184 and ratio rank #242 split - treat 257:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$19.2M
Median Employee Pay
$74,725
Pay Ratio
257:1
Filing Date
2026-03-31

Company Info

CIK
818686
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
L3
View SEC filings →
SEC EDGAR DEF 14A for CIK 818686, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Teva Pharmaceutical Industries Ltd's FY2025 ratio 257:1 ranks #9 of 168 Chemicals & Pharmaceuticals filers (95th percentile).

Read with Teva Pharmaceutical Industries Ltd

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps STEEP · PEAK · HIGH-MED.

Churchill Downs Inc · PEAK

ABS(ceo_total_comp) peer at $19.2M (Δ $4K heavier vs Teva Pharmaceutical Industries Ltd); EXTREME · LOW-MED vs this page's STEEP · PEAK · HIGH-MED.
Align Technology Inc · PEAK

ABS(ceo_total_comp) peer at $19.2M (Δ $18K heavier vs Teva Pharmaceutical Industries Ltd); EXTREME · LOW-MED vs this page's STEEP · PEAK · HIGH-MED.
Delta Air Lines, Inc. · PEAK

ABS(ceo_total_comp) peer at $19.2M (Δ $54K heavier vs Teva Pharmaceutical Industries Ltd); STEEP · HIGH-MED vs this page's STEEP · PEAK · HIGH-MED.
Aptiv PLC · PEAK

ABS(ceo_total_comp) peer at $19.3M (Δ $82K heavier vs Teva Pharmaceutical Industries Ltd); MEGA · LOW-MED vs this page's STEEP · PEAK · HIGH-MED.
Harrow, Inc. (SIC 28 pole)

Harrow, Inc. stamps STEEP · PEAK nearest in-SIC by ABS(pay_ratio) to Teva Pharmaceutical Industries Ltd's STEEP filing.
National dual ranks · #184/#242

Teva Pharmaceutical Industries Ltd's FY2025 package sits #184 by CEO dollars and #242 by ratio under PEAK · STEEP.
Comp structure · PEAK

Teva Pharmaceutical Industries Ltd's PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for Teva Pharmaceutical Industries Ltd (CIK 818686), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.